Skip to Main Content

Paper Details

Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.
J Med Chem
19
2020
Author NameAffiliation
Dalia Barsyte-LovejoyUniversity of Toronto
Cheryl H ArrowsmithUniversity of Toronto
Cheryl H ArrowsmithPrincess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto
Jian JinMount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 4

Datasets

Release 1.2